Form 8.3 - AON PLC

Form 8.3 - AON PLC

BARCLAYS PLC

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 14 September 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

346,913

0.15%

2,358,382

1.02%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

528,090

0.23%

33,200

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

107,299

0.05%

106,599

0.05%

 

 

 

 

TOTAL:

 

 

 

 

982,302

0.42%

2,498,181

1.08%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

1

202.7300 USD
Purchase

1

203.0000 USD
Purchase

2

201.9900 USD
Purchase

8

202.3900 USD
Purchase

9

203.1177 USD
Purchase

26

202.7000 USD
Purchase

28

203.0600 USD
Purchase

33

203.3300 USD
Purchase

39

202.7435 USD
Purchase

41

203.2100 USD
Purchase

42

203.0738 USD
Purchase

51

203.1959 USD
Purchase

65

203.0936 USD
Purchase

75

202.4650 USD
Purchase

78

203.0680 USD
Purchase

82

203.2867 USD
Purchase

100

203.2550 USD
Purchase

108

201.7800 USD
Purchase

115

203.2200 USD
Purchase

122

203.1617 USD
Purchase

200

202.7400 USD
Purchase

235

203.3560 USD
Purchase

240

202.1958 USD
Purchase

304

202.7433 USD
Purchase

400

202.5000 USD
Purchase

701

202.8641 USD
Purchase

803

202.6212 USD
Purchase

1,169

201.9600 USD
Purchase

3,900

202.6907 USD
Purchase

4,983

203.1755 USD
Purchase

6,126

202.4178 USD
Purchase

8,966

201.9048 USD
Purchase

9,347

202.8094 USD
Purchase

11,470

202.9791 USD
Purchase

12,680

202.1572 USD
Purchase

16,975

202.4115 USD
Sale

7

202.0000 USD
Sale

26

202.8569 USD
Sale

33

203.3300 USD
Sale

41

202.9348 USD
Sale

51

203.0700 USD
Sale

52

203.3400 USD
Sale

54

203.2357 USD
Sale

75

202.4650 USD
Sale

100

203.0000 USD
Sale

100

203.3000 USD
Sale

100

203.4700 USD
Sale

200

202.5900 USD
Sale

200

204.0250 USD
Sale

205

201.9600 USD
Sale

256

203.2321 USD
Sale

302

203.3263 USD
Sale

324

202.8741 USD
Sale

377

203.0248 USD
Sale

395

201.8600 USD
Sale

400

202.6787 USD
Sale

400

203.2425 USD
Sale

426

203.0592 USD
Sale

500

201.9780 USD
Sale

511

201.8813 USD
Sale

559

202.9054 USD
Sale

629

203.1011 USD
Sale

700

203.6542 USD
Sale

728

201.9668 USD
Sale

762

202.0086 USD
Sale

895

202.3928 USD
Sale

900

202.9333 USD
Sale

1,349

201.8800 USD
Sale

1,668

202.6140 USD
Sale

2,200

202.5632 USD
Sale

2,655

203.9018 USD
Sale

3,024

202.8897 USD
Sale

4,407

203.2145 USD
Sale

4,409

202.5328 USD
Sale

5,052

202.3012 USD
Sale

5,898

201.9660 USD
Sale

8,547

202.8643 USD
Sale

10,421

202.1416 USD
Sale

19,497

202.3090 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

15 Sep 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or

Number of

Exercise Type Expiry
purchased

relevant securities

price date

to which the option

or derivative

relates

Call Options Purchased

700

195.0000

American Sep 18, 2020
Put Options Purchased

-106,599

214.5780

European Oct 20, 2020
Put Options Written

106,599

214.5780

European Oct 20, 2020

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

UK 100

Latest directors dealings